- Amended Statement of Beneficial Ownership (SC 13D/A)
10 Febbraio 2011 - 8:04PM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D/A
Under the Securities Exchange Act of 1934
(AMENDMENT NO.
10
)
Information to be Included in Statements Filed Pursuant
to Rule 13d-1(a) and Amendments Thereto Filed Pursuant to Rule 13d-2(a)
Engex, Inc.
(Name of Issuer)
COMMON STOCK, $.10 PAR VALUE
(Title of Class of Securities
292851102
(CUSIP Number)
David Selengut, Esq.
c/o Ellenoff Grossman & Schole LLP
150 East 42
nd
Street
New York, NY 10017
(212) 370-1300
______________________________________________________________________
(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
January 31, 2011
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box.
¨
Note:
schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7(b) for other parties to whom copies are to be sent.
*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
Page 1 of 6 pages
SCHEDULE 13D/A
CUSIP No.
292851102
|
Page 2 of 6 pages
|
1
|
NAME OF REPORTING PERSON
J. Morton Davis
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a)
[ ]
(b)
[ ]
|
3
|
SEC USE ONLY
|
4
|
SOURCE OF FUNDS*
See Item #3 herein
|
5
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
|
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
United States
|
NUMBER OF
SHARES
BY
EACH
REPORTING
PERSON WITH
|
7
|
SOLE VOTING POWER
709,869
|
8
|
SHARED VOTING POWER
0
|
9
|
SOLE DISPOSITIVE POWER
709,869
|
10
|
SHARED DISPOSITIVE POWER
0
|
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,036,693
|
12
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
|
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
63.75%
|
14
|
TYPE OF REPORTING PERSON*
IN
|
|
*SEE INSTRUCTIONS BEFORE FILLING OUT!
|
SCHEDULE 13D/A
CUSIP No.
292851102
|
Page 3 of 6 pages
|
1
|
NAME OF REPORTING PERSON
Rosalind Davidowitz
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a)
[ ]
(b)
[ ]
|
3
|
SEC USE ONLY
|
4
|
SOURCE OF FUNDS*
See Item #3 herein
|
5
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
|
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
United States
|
NUMBER OF
SHARES
BY
EACH
REPORTING
PERSON WITH
|
7
|
SOLE VOTING POWER
326,824
|
8
|
SHARED VOTING POWER
0
|
9
|
SOLE DISPOSITIVE POWER
326,824
|
10
|
SHARED DISPOSITIVE POWER
0
|
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,036,693
|
12
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
|
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
63.75%
|
14
|
TYPE OF REPORTING PERSON*
IN
|
|
*SEE INSTRUCTIONS BEFORE FILLING OUT!
|
SCHEDULE 13D/A
CUSIP No.
292851102
|
Page 4 of 6 pages
|
1
|
NAME OF REPORTING PERSON
Rivkalex Corp.
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a)
[ ]
(b)
[ ]
|
3
|
SEC USE ONLY
|
4
|
SOURCE OF FUNDS*
See Item #3 herein
|
5
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
|
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
New York
|
NUMBER OF
SHARES
BY
EACH
REPORTING
PERSON WITH
|
7
|
SOLE VOTING POWER
167,429
|
8
|
SHARED VOTING POWER
0
|
9
|
SOLE DISPOSITIVE POWER
167,429
|
10
|
SHARED DISPOSITIVE POWER
0
|
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
167,429
|
12
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
|
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
10.2%
|
14
|
TYPE OF REPORTING PERSON*
CO.
|
|
*SEE INSTRUCTIONS BEFORE FILLING OUT!
|
J. Morton Davis, Rosalind Davidowitz and Rivkalex Corporation ("Rivkalex"), (collectively, the "Reporting Parties") hereby amend the following Items in their statement on Schedule 13D relating to the common stock, $.10 par value ("shares") of Engex, Inc. (the "Issuer")as follows:
Item 3. is hereby amended by adding the following new paragraph thereto:
Since the previously filed Schedule 13D, Amendment No. 9, Rosalind Davidowitz used her personal funds to purchase the additional shares.
Item 4. is hereby partially amended as follows:
The purchases were for investment purposes only and not to effect any plan described in (a) - (j) of Item 4.
Item 5. (a) is hereby amended in its entirety as follows:
As of January 31, 2011, Mr. Davis may be deemed to beneficially own 1,036,693 shares (4) or 63.75% of the Issuer's shares as follows: (i) 58,854 shares owned by D.H. Blair Investment Banking Corp. ("Blair Investment"), (ii) 167,429 shares owned by Rivkalex Corporation, (iii) 159,395 shares owned by Rosalind Davidowitz, and (iv) 651,015 shares owned directly by J. Morton Davis.
As of January 31, 2011, Rosalind Davidowitz may be deemed to beneficially own 1,036,693 shares or 63.75% of the Issuer's shares as indicated in (i) - (iv) above.(5).
As of January 31, 2011, Rivkalex may be deemed to beneficially own 167,429 shares or 10.2% of the Issuer's shares.
(c) On December 1, 2010, Rosalind Davidowitz purchased 1,800 shares at prices between $3.50 and $3.67 per share. On December 15, 2010, she purchased 500 shares at prices between $3.60 and $3.83 and on December 20, 2010 she purchased 100 shares at $3.61 per share. All the purchases were made in the open market.
____________________________________________
(4) Although Mr. Davis is including securities owned by Rosalind Davidowitz and Rivkalex in the aggregate amount of shares owned by him, filing of this statement shall not be deemed an admission by J. Morton Davis that he beneficially owns the securities attributed to Rosalind Davidowitz or Rivkalex for any purpose. J. Morton Davis expressly disclaims beneficial ownership of all securities held by Rosalind Davidowitz and Rivkalex.
(5) Although Mrs. Davidowitz is including securities owned by J. Morton Davis and Blair Investment in the aggregate amount of shares owned by her, filing of this statement shall not be deemed an admission by Mrs. Davidowitz that she beneficially owns the securities attributed to J. Morton Davis or Blair Investment for any purpose. Mrs. Davidowitz expressly disclaims beneficial ownership of all securities held by J. Morton Davis and Blair Investment.
Page 5 of 6 pages
SIGNATURES
After reasonable inquiry and to the best of my knowledge and belief, we certify that the information set forth in this statement is true, complete and correct.
Date: February 10, 2011
New York, New York
|
/
s/ J. Morton Davis
J. Morton Davis
|
Date: February 10, 2011
New York, New York
|
/s/ Rosalind Davidowitz
Rosalind Davidowitz
|
Date: February 10, 2011
New York, New York
|
RIVKALEX CORPORATION
By:
/s/ Rosalind Davidowitz
Rosalind Davidowitz
|
Page 6 of 6 pages
Grafico Azioni Engex (AMEX:EGX)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Engex (AMEX:EGX)
Storico
Da Giu 2023 a Giu 2024